Elanix Biotechnologies Overview

  • Founded
  • 2012

Founded
  • Status
  • Public

  • Employees
  • 10

Employees
  • Stock Symbol
  • ELN

Stock Symbol
  • Share Price
  • $0.12

  • (As of Tuesday Closing)

Elanix Biotechnologies General Information

Description

Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
FRA
Primary Office
  • Route de la Corniche 4
  • Bâtiment Lysine
  • 1066 Epalinges
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elanix Biotechnologies Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.12 $0.15 $0.11 - $0.32 1.75K

Elanix Biotechnologies Financials Summary

In Thousands,
USD
TTM 31-Dec-2018 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016
EV 12,162 12,162 22,645 27,389
Revenue 73 73 256 7
EBITDA (4,066) (4,066) (3,917) (2,568)
Net Income (4,402) (4,402) (3,378) (2,091)
Total Assets 1,233 1,233 2,958 22,933
Total Debt 0 0 202 542
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Elanix Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Elanix Biotechnologies‘s full profile, request access.

Request a free trial

Elanix Biotechnologies Executive Team (10)

Name Title Board Seat Contact Info
Tomas Svoboda Chief Executive Officer
Egon Minar Chief Operating Officer & Chief Financial Officer
Anthony De Buys Roessingh Co-Founder
Corinne Scaletta Co-Founder
Lee Ann Applegate Ph.D Co-Founder
You’re viewing 5 of 10 executive team members. Get the full list »

Elanix Biotechnologies Board Members (1)

Name Representing Role Since
0000 0000000 Elanix Biotechnologies Chairwoman of Supervisory Board & Owner 000 0000
To view Elanix Biotechnologies’s complete board members history, request access »

Elanix Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elanix Biotechnologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Elanix Biotechnologies‘s full profile, request access.

Request a free trial